43P AKT and estrogen receptor (ER) inhibition potently impairs endocrine resistance (EndoR) in breast cancer (BC)
Titel:
43P AKT and estrogen receptor (ER) inhibition potently impairs endocrine resistance (EndoR) in breast cancer (BC)
Auteur:
Nardone, A. Morrison-Thiele, G. Goldstein, A. De Angelis, C. Veeraraghavan, J. Fu, X. Liu, C.C. Wang, T. Shea, M. Cosulich, S. Davies, B. Tsimelzon, A. Huang, S. Chamness, G. Jeselsohn, R. Malorni, L. Rimawi, M. Hilsenbeck, S. Osborne, C.K. Schiff, R.